R
Recursion Pharmaceuticals
🇺🇸USA
AI Healthcare
Awaira Score
65
Valuation
$2.18B
Total Raised
N/A
Awaira Score
65
Founded
2013
What They Build
Last updated: March 2026Public AI-driven drug discovery company combining biology, chemistry, and ML to industrialize drug discovery. Acquired Exscientia.
Funding Info
StagePublic
Employees800
Founder
C
Chris Gibson
Founder & CEO
Share
Loading sentiment...
Founded Same Year (2013)
Funding Timeline
Public · Last round data coming soon
Frequently Asked Questions
What is Recursion Pharmaceuticals's valuation?▾
Recursion Pharmaceuticals is valued at $2.2B.
Who invested in Recursion Pharmaceuticals?▾
Investor information for Recursion Pharmaceuticals is not publicly available at this time.
When did Recursion Pharmaceuticals last raise funding?▾
No public funding round data is currently available for Recursion Pharmaceuticals.
How many employees does Recursion Pharmaceuticals have?▾
Recursion Pharmaceuticals has approximately 800 employees.
What does Recursion Pharmaceuticals do?▾
Public AI-driven drug discovery company combining biology, chemistry, and ML to industrialize drug discovery. Acquired Exscientia.